Reyvow CENTURION trial results : Lilly migraine drug succeeds in phase 3 study
Reyvow CENTURION trial results : Eli Lilly and Company (Lilly) said that its migraine drug Reyvow (lasmiditan) has met the co-primary endpoint of a phase 3 clinical trial called CENTURION by delivering pain freedom from migraine attacks at 60 minutes and up to 48 hours. According to the US pharma giant, adults who were given Reyvow […]
Cipla gets FDA’s final approval for generic version of Migranal with CGT designation
May 21, 2020 No Comment
Cipla has secured final approval for its abbreviated new drug application (ANDA) for Dihydroergotamine Mesylate Nasal Spray 4mg/mL from the US Food and Drug Administration (FDA) with a competitive generic therapy (CGT) designation. The Indian pharma company said that it is the first approved applicant for such CGT and as a result is eligible for […]
Continue reading …
Ubrelvy FDA approval : Irish pharma company Allergan has bagged approval from the US Food and Drug Administration (FDA) for Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura in adults. Aura is a sensory phenomenon or visual disturbance. Ubrelvy is now the first orally-administered calcitonin gene-related peptide (CGRP) receptor […]
Continue reading …
Reyvow FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug Administration (FDA) for Reyvow (lasmiditan) for the acute treatment of migraine, irrespective of aura (a sensory phenomenon or visual disturbance), in adults. The oral treatment, which has been designed to bind to 5-HT1F receptors with high affinity, […]
Continue reading …Satsuma doses first patient in EMERGE clinical trial of STS101 in migraine
August 26, 2019 No Comment
US biopharma company Satsuma Pharmaceuticals has dosed the first patient in its phase 3 EMERGE clinical trial of STS101 (dihydroergotamine (DHE) nasal powder) for migraine treatment. The EMERGE efficacy trial is a single-dose, double-blind, randomized, placebo-controlled, parallel-group study to be held in multiple centers. The phase 3 clinical trial will feature nearly 1,140 migraine patients […]
Continue reading …
Lilly migraine drug Emgality FDA approval : Eli Lilly and Company (Lilly) has bagged approval from the US Food and Drug Administration (FDA) for Emgality (galcanezumab-gnlm) 120 mg injection as a prophylactic therapy for migraine in adults. Emgality, which is a calcitonin gene-related peptide (CGRP) antagonist, comes with a once-monthly, self-administered, subcutaneous injection. The Lilly […]
Continue reading …Ajovy FDA approval : Teva’s Ajovy approved in US for migraine prevention
September 16, 2018 No Comment
Ajovy FDA approval : Israeli pharma company Teva Pharmaceutical Industries has bagged the US Food and Drug Administration (FDA) approval for Ajovy (fremanezumab-vfrm) injection to be used for migraine prevention in adults. A humanized monoclonal antibody, Ajovy binds to calcitonin gene-related peptide (CGRP) ligand and prevents its binding to the receptor. Ajovy FDA approval for […]
Continue reading …
For the vast majority who encounter an intermittent headache, several pain-killers will as a rule do the trap. Migraine sufferers don’t have it so natural. Not just do numerous migraine medications have symptoms that include nausea and stomach ulcers to an expanded danger of stroke and even heart attack, many patients have additionally reported that […]
Continue reading …
Business News Today
- Boxlight acquires AV solutions provider Sahara Presentation System
- SSGT II acquires two self storage facilities near Tampa, Florida
- Preferred Apartment Communities to sell student housing portfolio to TREP
- Corbion, Total to build €200m PLA bioplastics plant in France
- iPipeline acquires Impact Financial Systems
- Nautilus Solar Energy acquires 17MW solar portfolio from Pine Gate Renewables
- Palladium Equity Partners acquires majority stake in Trachte USA from MPE Partners
- The Hilb Group acquires life and health agency Ganim Benefits in Connecticut
- La Brea Bakery to invest in automation processes at Van Nuys bakery
- REG begins construction on single wind turbine project in Minnesota
